← Back to Search

Radiation Therapy

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas (DOREMY Trial)

Phase 2
Waitlist Available
Led By Rick Haas, MD,PhD
Research Sponsored by The Netherlands Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying whether it is possible to reduce the amount of radiation given to patients before surgery for myxoid liposarcomas and still get the same tumor response.

Eligible Conditions
  • Liposarcoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: RadiationExperimental Treatment1 Intervention
Dose reduction of preoperative radiotherapy in MLS from 50 Gy to 36 GY.

Find a Location

Who is running the clinical trial?

The Netherlands Cancer InstituteLead Sponsor
302 Previous Clinical Trials
214,475 Total Patients Enrolled
1 Trials studying Liposarcoma
300 Patients Enrolled for Liposarcoma
Rick Haas, MD,PhDPrincipal InvestigatorThe Netherlands Cancer Institute
1 Previous Clinical Trials
12 Total Patients Enrolled
~5 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top